Kaczmarek, Leszek

Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory

Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R. M., Silva, A. J., Kaczmarek, L., & Huntley, G. W. (2006) · The Journal of Neuroscience

Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms

Cited by 499

Matrix Metalloproteinase-9 Undergoes Expression and Activation during Dendritic Remodeling in Adult Hippocampus

Szklarczyk, A., Lapinska, J., Rylski, M., McKay, R. D. G., & Kaczmarek, L. (2002) · The Journal of Neuroscience

Protease and Inhibitor MechanismsNeuroscience and Neuropharmacology Research

Cited by 392

MicroRNA Loss Enhances Learning and Memory in Mice

Konopka, W., Kiryk, A., Novak, M., Herwerth, M., Parkitna, J. R., Wawrzyniak, M., Kowarsch, A., Michaluk, P., Dzwonek, J., Arnsperger, T., et al. (2010) · The Journal of Neuroscience

MicroRNA in disease regulationMemory and Neural Mechanisms

Cited by 306

Important role of matrix metalloproteinase 9 in epileptogenesis

Wilczynski, G. M., Konopacki, F. A., Wilczek, E., Lasiecka, Z., Gorlewicz, A., Michaluk, P., Wawrzyniak, M., Malinowska, M., Okulski, P., Kolodziej, L. R., et al. (2008) · The Journal of Cell Biology

Epilepsy research and treatmentNeuroscience and Neuropharmacology Research

Cited by 292

Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology

Michaluk, P., Wawrzyniak, M., Alot, P., Szczot, M., Wyrembek, P., Mercik, K., Medvedev, N., Wilczek, E., De Roo, M., Zuschratter, W., et al. (2011) · Journal of Cell Science

Neuroscience and Neuropharmacology ResearchProtease and Inhibitor Mechanisms

Cited by 214

MMPs in learning and memory and neuropsychiatric disorders

Beroun, A., Mitra, S., Michaluk, P., Pijet, B., Stefaniuk, M., & Kaczmarek, L. (2019) · Cellular and Molecular Life Sciences

Protease and Inhibitor MechanismsNeuroscience and Neuropharmacology Research

Cited by 207

Functional anatomy of neural circuits regulating fear and extinction

Knapska, E., Macias, M., Mikosz, M., Nowak, A., Owczarek, D., Wawrzyniak, M., Pieprzyk, M., Cymerman, I. A., Werka, T., Sheng, M., et al. (2012) · Proceedings of the National Academy of Sciences

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 187

High MMP-9 activity levels in fragile X syndrome are lowered by minocycline

Dziembowska, M., Pretto, D. I., Janusz, A., Kaczmarek, L., Leigh, M. J., Gabriel, N., Durbin‐Johnson, B., Hagerman, R. J., & Tassone, F. (2013) · American Journal of Medical Genetics Part A

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 161

Role for MMP-9 in stress-induced downregulation of nectin-3 in hippocampal CA1 and associated behavioural alterations

van der Kooij, M. A., Fantin, M., Rejmak, E., Grosse, J., Zanoletti, O., Fournier, C., Ganguly, K., Kalita, K., Kaczmarek, L., & Sandi, C. (2014) · Nature Communications

Stress Responses and CortisolNeuroscience and Neuropharmacology Research

Cited by 140

The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.

Janusz, A., Miłek, J., Perycz, M., Pacini, L., Bagni, C., Kaczmarek, L., & Dziembowska, M. (2013) · The Journal of Neuroscience

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 112

High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses

Gawlak, M., Górkiewicz, T., Gorlewicz, A., Konopacki, F. A., Kaczmarek, L., & Wilczynski, G. M. (2009) · Neuroscience

Protease and Inhibitor MechanismsNeuroscience and Neuropharmacology Research

Cited by 101

Mechanism for long-term memory formation when synaptic strengthening is impaired

Radwanska, K., Medvedev, N. I., Pereira, G. S., Engmann, O., Thiede, N., Moraes, M. F. D., Villers, A., Irvine, E. E., Maunganidze, N. S., Pyza, E. M., et al. (2011) · Proceedings of the National Academy of Sciences

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 97

Synaptically released matrix metalloproteinase activity in control of structural plasticity and the cell surface distribution of GluA1-AMPA receptors

Szepesi, Z., Hosy, E., Ruszczycki, B., Bijata, M., Pyskaty, M., Bikbaev, A., Heine, M., Choquet, D., Kaczmarek, L., & Wlodarczyk, J. (2014) · PLoS ONE

Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders

Cited by 83

Brain-derived neurotrophic factor induces matrix metalloproteinase 9 expression in neurons via the serum response factor/c-Fos pathway

Kuzniewska, B., Rejmak, E., Malik, A. R., Jaworski, J., Kaczmarek, L., & Kalita, K. (2013) · Molecular and Cellular Biology

Nerve injury and regenerationProtease and Inhibitor Mechanisms

Cited by 82

Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.

Rybakowski, J. K., Skibinska, M., Kapelski, P., Kaczmarek, L., & Hauser, J. (2009) · Schizophrenia Research

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 76

Maintenance of long-term potentiation in hippocampal mossy fiber-CA3 pathway requires fine-tuned MMP-9 proteolytic activity

Wiera, G., Wozniak, G., Bajor, M., Kaczmarek, L., & Mozrzymas, J. W. (2013) · Hippocampus

Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms

Cited by 57

Experience-dependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO

Kaliszewska, A., Bijata, M., Kaczmarek, L., & Kossut, M. (2012) · Cerebral Cortex

Tactile and Sensory InteractionsNeurogenesis and neuroplasticity mechanisms

Cited by 55

Gene expression in learning processes

Kaczmarek, L. (2000) · Acta Neurobiologiae Experimentalis

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 44

Extracellular matrix modulation is driven by experience-dependent plasticity during stroke recovery.

Quattromani, M. J., Pruvost, M., Guerreiro, C., Backlund, F., Englund, E., Aspberg, A., Jaworski, T., Hakon, J., Ruscher, K., Kaczmarek, L., et al. (2018) · Molecular Neurobiology

Stroke Rehabilitation and RecoveryNeurogenesis and neuroplasticity mechanisms

Cited by 39

A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms.

Lepeta, K., Purzycka, K. J., Pachulska‐Wieczorek, K., Mitjans, M., Begemann, M., Vafadari, B., Bijata, K., Adamiak, R. W., Ehrenreich, H., Dziembowska, M., et al. (2017) · EMBO Molecular Medicine

Schizophrenia research and treatmentGenetics and Neurodevelopmental Disorders

Cited by 39

Author Reply to Peer Reviews of BDNF signaling requires Matrix Metalloproteinase-9 during structural synaptic plasticity

Legutko, D., Kuźniewska, B., Kalita, K., Yasuda, R., Kaczmarek, L., & Michaluk, P. (2024)

Neuroscience and Neuropharmacology ResearchNerve injury and regeneration

Cited by 5